Skip to main content
Clinical Trials/NCT01787604
NCT01787604
Completed
Not Applicable

Superiority Trial of Aortic Root Reimplantation Procedure Versus Aortic Valve Reimplantation Procedure

Meshalkin Research Institute of Pathology of Circulation1 site in 1 country64 target enrollmentJanuary 2011

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Ascending Aortic Aneurism
Sponsor
Meshalkin Research Institute of Pathology of Circulation
Enrollment
64
Locations
1
Primary Endpoint
Freedom From Aortic Insufficiency More Than 2+ (Percentage, Kaplan-Meier)
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

Authors hypothesize that aortic root reimplantation procedure is superior over standard aortic valve reimplantation procedure in the incidence of aortic valve replacement.

Detailed Description

A single blind prospective randomized superiority study is conducted. Our hypothesis is that there is difference in the incidence of aortic valve replacement between the standard aortic valve reimplantation procedure and aortic root reimplantation procedure more than 21.1%. If there is truly difference between groups (Aortic Root Reimplantation Procedure and Aortic Valve Reimplantation Procedure), then total 64 patients for both groups are required to be 80% sure that the upper limit of a one-sided 95% confidence interval would reveal a difference in favour of the Aortic Root Reimplantation Procedure of 21.1%. The blinding process is applied to a patient, who is informed about received valve-sparing operation, but don't know the type of the last. The study was approved by Institutional Review Board. Depending on a type of the procedure, the patients are divided into two groups: Aortic Root Reimplantation Procedure group includes 32 patients and Aortic Valve Reimplantation Procedure group consists of 32 patients. Randomization is conducted intraoperatively by using accidental sampling after examining the aortic valve and making a decision on the possibility of a valve-sparing operation.

Registry
clinicaltrials.gov
Start Date
January 2011
End Date
November 20, 2015
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Meshalkin Research Institute of Pathology of Circulation
Responsible Party
Principal Investigator
Principal Investigator

Dmitry Khvan

cardiac surgeon

Meshalkin Research Institute of Pathology of Circulation

Eligibility Criteria

Inclusion Criteria

  • Aortic insufficiency 2+
  • Ascending aorta or aortic root of greater than 4.5 cm (\> 4.0 cm in Marfan syndrome)
  • Good conditions of aortic cusps

Exclusion Criteria

  • Aortic annulus more than 32 mm
  • Aortic cusps destruction
  • Critical aortic cusps elongation
  • Aortic root dissection

Outcomes

Primary Outcomes

Freedom From Aortic Insufficiency More Than 2+ (Percentage, Kaplan-Meier)

Time Frame: up to 4 yeras

Estimated percentage of participants free from aortic insufficiency (AI) more than 2+ measured by echocardiography for a 4 years after treatment..

Secondary Outcomes

  • Survival (Percentage, Kaplan-Meier)(up to 4 yeras)

Study Sites (1)

Loading locations...

Similar Trials